![](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/49168159b2519be46ccd18fcc43bf165ffbc2a3d-1200x675.jpg?fit=crop&auto=format)
Post-HCT Cyclophosphamide Yields Similar Outcomes in GVHD Subgroups
Posttransplant treatment with cyclophosphamide showed comparable overall survival (OS) and graft-versus-host disease (GVHD)–free relapse-free survival (GRFS) outcomes vs calcineurin inhibitor (CNI)–based prophylaxis in either matched or mismatched …